thyroxine has been researched along with Breech Presentation in 8 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Breech Presentation: A malpresentation of the FETUS at near term or during OBSTETRIC LABOR with the fetal cephalic pole in the fundus of the UTERUS. There are three types of breech: the complete breech with flexed hips and knees; the incomplete breech with one or both hips partially or fully extended; the frank breech with flexed hips and extended knees.
| Excerpt | Relevance | Reference |
|---|---|---|
| "At term, foetal breech presentation and caesarean section rate were significantly higher (P = 0·006 and P = 0·026, respectively) than in the euthyroid controls." | 1.46 | First trimester isolated maternal hypothyroxinaemia: adverse maternal metabolic profile and impact on the obstetrical outcome. ( Bernard, P; Daumerie, C; Furnica, RM; Gruson, D; Lazarus, JH; Maiter, D, 2017) |
| "The prevalence rates of breech presentation in these women were all higher compared to the prevalence of breech in women below these cut-offs (df = 1, P < 0·01)." | 1.36 | High thyrotrophin levels at end term increase the risk of breech presentation. ( Hasaart, TH; Kooistra, L; Kuppens, SM; Oei, SG; Pop, VJ; Vader, HL; Wijnen, HA, 2010) |
| "To evaluate the relationship between breech presentation at term (>/= 37 weeks of gestation) and maternal thyroid hormone activity in early gestation." | 1.36 | Maternal thyroid hormones in early pregnancy and risk of breech presentation. ( Bamforth, F; Burstyn, I; Salehidobakhshari, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knight, BA | 1 |
| Shields, BM | 1 |
| Sturley, R | 1 |
| Vaidya, B | 1 |
| Vissenberg, R | 1 |
| Vrijkotte, TG | 1 |
| van der Post, JA | 1 |
| Fliers, E | 1 |
| Goddijn, M | 1 |
| Bisschop, PH | 1 |
| Guedes Ramallo, P | 1 |
| Boix Carreño, E | 1 |
| Furnica, RM | 1 |
| Gruson, D | 1 |
| Lazarus, JH | 1 |
| Maiter, D | 1 |
| Bernard, P | 1 |
| Daumerie, C | 1 |
| Kooistra, L | 2 |
| Kuppens, SM | 2 |
| Hasaart, TH | 2 |
| Vader, HL | 3 |
| Wijnen, HA | 1 |
| Oei, SG | 1 |
| Pop, VJ | 3 |
| Salehidobakhshari, M | 1 |
| Bamforth, F | 1 |
| Burstyn, I | 1 |
| van der Donk, RW | 1 |
| Oei, GS | 1 |
| Brouwers, EP | 1 |
| Wijnen, H | 1 |
| Oei, G | 1 |
| Essed, GG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Detection of Thyrotrophin Receptor in Human Myometrium[NCT01348191] | 10 participants (Actual) | Observational | 2011-11-30 | Completed | |||
| Ebis: The Eindhoven Breech Intervention Study[NCT00516555] | 250 participants (Actual) | Observational | 2007-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for thyroxine and Breech Presentation
| Article | Year |
|---|---|
Maternal thyroid function and the outcome of external cephalic version: a prospective cohort study.
Topics: Adult; Breech Presentation; Female; Humans; Logistic Models; Middle Aged; Pregnancy; Prospective Stu | 2011 |
7 other studies available for thyroxine and Breech Presentation
| Article | Year |
|---|---|
Maternal thyroid function in pregnant women with a breech presentation in late gestation.
Topics: Adult; Breech Presentation; Female; Gestational Age; Humans; Pregnancy; Thyroid Gland; Thyrotropin; | 2016 |
Abnormal thyroid function parameters in the second trimester of pregnancy are associated with breech presentation at term: a nested cohort study.
Topics: Adult; Breech Presentation; Female; Gestational Age; Humans; Pregnancy; Pregnancy Trimester, Second; | 2016 |
Management of pseudohypoparathyroidism in pregnancy: a case report.
Topics: Adult; Breech Presentation; Calcium; Cesarean Section; Chromogranins; DNA Methylation; Female; GTP-B | 2017 |
First trimester isolated maternal hypothyroxinaemia: adverse maternal metabolic profile and impact on the obstetrical outcome.
Topics: Adult; Body Mass Index; Breech Presentation; Cesarean Section; Female; Fetal Macrosomia; Humans; Mot | 2017 |
High thyrotrophin levels at end term increase the risk of breech presentation.
Topics: Adult; Autoantibodies; Breech Presentation; Female; Humans; Iodide Peroxidase; Labor Presentation; P | 2010 |
Maternal thyroid hormones in early pregnancy and risk of breech presentation.
Topics: Adult; Breech Presentation; Case-Control Studies; Female; Gestational Age; Humans; Logistic Models; | 2010 |
Low concentrations of maternal thyroxin during early gestation: a risk factor of breech presentation?
Topics: Biomarkers; Breech Presentation; Cohort Studies; Female; Gestational Age; Humans; Hypothyroidism; Ob | 2004 |